Overview
Mateusz Opyrchal is an Oncologist in Avon, Indiana. Dr. Opyrchal is highly rated in 12 conditions, according to our data. His top areas of expertise are Breast Cancer, Angiosarcoma, HER-2 Positive Breast Cancer, and Paget Disease of the Breast.
His clinical research consists of co-authoring 70 peer reviewed articles and participating in 12 clinical trials. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- EPO
- HMO
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- EPO
- MANAGED MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MANAGED MEDICAID
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
- MEDICARE MAPD
- MEDICARE SNP
Locations
1111 Ronald Reagan Pkwy, Avon, IN 46123
550 University Blvd, Indianapolis, IN 46202
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
11 Clinical Trials
Univ. Radiation Oncology Associates Inc.
Lawrence Einhorn is an Oncologist in Indianapolis, Indiana. Dr. Einhorn is highly rated in 20 conditions, according to our data. His top areas of expertise are Testicular Cancer, Teratoma of the Mediastinum, Testicular Yolk Sac Tumor, Orchiectomy, and Bone Marrow Transplant.
Office
Nasser Hanna is an Oncologist in Indianapolis, Indiana. Dr. Hanna is highly rated in 21 conditions, according to our data. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Testicular Cancer, Orchiectomy, and Bone Marrow Transplant.
Univ. Radiation Oncology Associates Inc.
Patrick Loehrer is an Oncologist in Indianapolis, Indiana. Dr. Loehrer is highly rated in 18 conditions, according to our data. His top areas of expertise are Thymic Epithelial Tumor, Colorectal Cancer, Pancreatic Cancer, Pancreaticoduodenectomy, and Thymectomy.
Frequently Asked Questions about Dr. Mateusz Opyrchal
How do I make an appointment with Dr. Mateusz Opyrchal?
You can book an appointment with Dr. Mateusz Opyrchal by calling their office at 317-274-8660. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Mateusz Opyrchal a top-rated expert for Breast Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mateusz Opyrchal is classified as an Elite expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Mateusz Opyrchal specialize in?
While Dr. Mateusz Opyrchal is a Oncology, they have specific expertise in Breast Cancer, Angiosarcoma, and HER-2 Positive Breast Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Mateusz Opyrchal participate in research or clinical trials?
Yes. Dr. Mateusz Opyrchal has published 70 articles and abstracts on conditions like Breast Cancer. You can view a list of Dr. Mateusz Opyrchal's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Mateusz Opyrchal accept my insurance?
Dr. Mateusz Opyrchal accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 317-274-8660 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Breast CancerDr. Opyrchal isElite. Learn about Breast Cancer.
- Distinguished
- AngiosarcomaDr. Opyrchal isDistinguished. Learn about Angiosarcoma.
- HER-2 Positive Breast CancerDr. Opyrchal isDistinguished. Learn about HER-2 Positive Breast Cancer.
- Inflammatory Breast CancerDr. Opyrchal isDistinguished. Learn about Inflammatory Breast Cancer.
- Paget Disease of the BreastDr. Opyrchal isDistinguished. Learn about Paget Disease of the Breast.
- Advanced
- Adult Soft Tissue SarcomaDr. Opyrchal isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- Bone TumorDr. Opyrchal isAdvanced. Learn about Bone Tumor.
- Epithelioid SarcomaDr. Opyrchal isAdvanced. Learn about Epithelioid Sarcoma.
- FibrosarcomaDr. Opyrchal isAdvanced. Learn about Fibrosarcoma.
- Myxoid LiposarcomaDr. Opyrchal isAdvanced. Learn about Myxoid Liposarcoma.
- Rhabdomyosarcoma EmbryonalDr. Opyrchal isAdvanced. Learn about Rhabdomyosarcoma Embryonal.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Opyrchal isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloblastic Leukemia with MaturationDr. Opyrchal isExperienced. Learn about Acute Myeloblastic Leukemia with Maturation.
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Opyrchal isExperienced. Learn about Acute Myeloid Leukemia (AML).
- AgranulocytosisDr. Opyrchal isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Opyrchal isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.